RNS Number : 3032Q
Legal & General UCITS ETF PLC
17 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
17/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137470685.86 |
11.682 |
| L&G UK Equity UCITS ETF |
17/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11121173.44 |
9.268 |
| L&G Global Equity UCITS ETF |
17/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32761249.13 |
11.297 |
| L&G Japan Equity UCITS ETF |
17/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
118138746.59 |
10.658 |
| L&G Europe ex UK Equity UCITS ETF |
17/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
99927362.69 |
10.790 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
17/06/2020 |
IE00BFXR5W90 |
4505639 |
USD |
46900319.46 |
10.409 |
| L&G Clean Water UCITS ETF |
17/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15542541.80 |
10.362 |
| L&G Artificial Intelligence UCITS ETF |
17/06/2020 |
IE00BK5BCD43 |
5500000 |
USD |
67709547.46 |
12.311 |
| L&G Healthcare Innovation UCITS ETF |
17/06/2020 |
IE00BK5BC677 |
2600000 |
USD |
31845686.60 |
12.248 |
| L&G Pharma Breakthrough UCITS ETF |
17/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
29456116.16 |
11.782 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
17/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
94058192.22 |
10.224 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
17/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
601487454.42 |
10.479 |
| L&G Battery Value-Chain UCITS ETF |
17/06/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
122718882.97 |
9.297 |
| L&G Ecommerce Logistics UCITS ETF |
17/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
57908406.78 |
10.529 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
17/06/2020 |
IE00BMW3QX54 |
47330616 |
USD |
809305015.39 |
17.099 |
| L&G Cyber Security UCITS ETF |
17/06/2020 |
IE00BYPLS672 |
84436776 |
USD |
1563711811.18 |
18.519 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGMVZNNGGZZ
